Treace Medical Concepts, Inc. Increase (Decrease) in Accounts Payable
Treace Medical Concepts, Inc. (TMCI) reported Increase (Decrease) in Accounts Payable of $9.34 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayable · last filed 2026-08-07
- Treace Medical Concepts, Inc. increase (decrease) in accounts payable for the quarter ending 2026-06-30 was $2.52M, a 62.53% decline year-over-year.
- Treace Medical Concepts, Inc. increase (decrease) in accounts payable for the quarter ending 2026-03-31 was $6.81M, a 152.17% increase year-over-year.
- Treace Medical Concepts, Inc. increase (decrease) in accounts payable for the quarter ending 2025-12-31 was -$9.38M.
- Treace Medical Concepts, Inc. increase (decrease) in accounts payable for the quarter ending 2025-09-30 was -$3.86M, a 769.44% decline year-over-year.
- Treace Medical Concepts, Inc. increase (decrease) in accounts payable for fiscal 2025 was -$3.80M.
- Treace Medical Concepts, Inc. increase (decrease) in accounts payable for fiscal 2024 was -$1.31M, a 141.46% decline from fiscal 2023.
- Treace Medical Concepts, Inc. increase (decrease) in accounts payable for fiscal 2023 was $3.17M, a 31.33% decline from fiscal 2022.
- Treace Medical Concepts, Inc. increase (decrease) in accounts payable for fiscal 2022 was $4.61M, a 157.51% increase from fiscal 2021.
| Period end | Increase (Decrease) in Accounts Payable 3 month | Increase (Decrease) in Accounts Payable 6 month | Increase (Decrease) in Accounts Payable 9 month | Increase (Decrease) in Accounts Payable 12 month |
|---|---|---|---|---|
| 2026-06-30 | $2.52M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $9.34M 10-Q · filed 2026-08-07 | -$42.00K derived: sum of 3 quarters · filed 2026-08-07 | -$3.90M derived: sum of 4 quarters · filed 2026-08-07 |
| 2026-03-31 | $6.81M 10-Q · filed 2026-05-08 | -$2.57M derived: sum of 2 quarters · filed 2026-05-08 | -$6.42M derived: sum of 3 quarters · filed 2026-05-08 | $314.00K derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-12-31 | -$9.38M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | -$13.23M derived: sum of 2 quarters · filed 2026-02-27 | -$6.50M derived: sum of 3 quarters · filed 2026-08-07 | -$3.80M 10-K · filed 2026-02-27 |
| 2025-09-30 | -$3.86M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $2.88M derived: sum of 2 quarters · filed 2026-08-07 | $5.58M 10-Q · filed 2025-11-06 | -$2.55M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-06-30 | $6.74M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $9.44M 10-Q · filed 2026-08-07 | $1.31M derived: sum of 3 quarters · filed 2026-08-07 | $1.89M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-03-31 | $2.70M 10-Q · filed 2026-05-08 | -$5.43M derived: sum of 2 quarters · filed 2026-05-08 | -$4.85M derived: sum of 3 quarters · filed 2026-05-08 | -$7.93M derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | -$8.13M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | -$7.55M derived: sum of 2 quarters · filed 2026-02-27 | -$10.63M derived: sum of 3 quarters · filed 2026-02-27 | -$1.31M 10-K · filed 2026-02-27 |
| 2024-09-30 | $576.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$2.50M derived: sum of 2 quarters · filed 2025-11-06 | $6.81M 10-Q · filed 2025-11-06 | $9.97M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-06-30 | -$3.08M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $6.24M 10-Q · filed 2025-08-07 | $9.39M derived: sum of 3 quarters · filed 2026-02-27 | $9.93M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-03-31 | $9.31M 10-Q · filed 2025-05-08 | $12.47M derived: sum of 2 quarters · filed 2026-02-27 | $13.00M derived: sum of 3 quarters · filed 2026-02-27 | $16.07M derived: sum of 4 quarters · filed 2026-02-27 |
| 2023-12-31 | $3.15M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $3.69M derived: sum of 2 quarters · filed 2026-02-27 | $6.76M derived: sum of 3 quarters · filed 2026-02-27 | $3.17M 10-K · filed 2026-02-27 |
| 2023-09-30 | $534.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-05 | $3.60M derived: sum of 2 quarters · filed 2024-11-05 | $12.00K 10-Q · filed 2024-11-05 | $799.00K derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | $3.07M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | -$522.00K 10-Q · filed 2024-08-06 | $265.00K derived: sum of 3 quarters · filed 2025-02-27 | $5.05M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | -$3.59M 10-Q · filed 2024-05-07 | -$2.81M derived: sum of 2 quarters · filed 2025-02-27 | $1.98M derived: sum of 3 quarters · filed 2025-02-27 | $1.63M derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | $787.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $5.57M derived: sum of 2 quarters · filed 2025-02-27 | $5.22M derived: sum of 3 quarters · filed 2025-02-27 | $4.61M 10-K · filed 2025-02-27 |
| 2022-09-30 | $4.78M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $4.43M derived: sum of 2 quarters · filed 2023-11-09 | $3.83M 10-Q · filed 2023-11-09 | $5.44M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-06-30 | -$350.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | -$957.00K 10-Q · filed 2023-08-09 | $657.00K derived: sum of 3 quarters · filed 2024-02-27 | $178.00K derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-03-31 | -$607.00K 10-Q · filed 2023-05-09 | $1.01M derived: sum of 2 quarters · filed 2024-02-27 | $528.00K derived: sum of 3 quarters · filed 2024-02-27 | $2.36M derived: sum of 4 quarters · filed 2024-02-27 |
| 2021-12-31 | $1.61M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $1.14M derived: sum of 2 quarters · filed 2024-02-27 | $2.96M derived: sum of 3 quarters · filed 2024-02-27 | $1.79M 10-K · filed 2024-02-27 |
| 2021-09-30 | -$479.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $1.35M derived: sum of 2 quarters · filed 2022-11-09 | $177.00K 10-Q · filed 2022-11-09 | -$631.00K derived: sum of 4 quarters · filed 2023-03-08 |
| 2021-06-30 | $1.83M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-10 | $656.00K 10-Q · filed 2022-08-10 | -$152.00K derived: sum of 3 quarters · filed 2023-03-08 | $919.00K derived: sum of 4 quarters · filed 2023-03-08 |
| 2021-03-31 | -$1.17M 10-Q · filed 2022-05-06 | -$1.98M derived: sum of 2 quarters · filed 2023-03-08 | -$910.00K derived: sum of 3 quarters · filed 2023-03-08 | -$1.30M derived: sum of 4 quarters · filed 2023-03-08 |
| 2020-12-31 | -$808.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-08 | $263.00K derived: sum of 2 quarters · filed 2023-03-08 | -$131.00K derived: sum of 3 quarters · filed 2023-03-08 | $1.33M 10-K · filed 2023-03-08 |
| 2020-09-30 | $1.07M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $677.00K derived: sum of 2 quarters · filed 2021-11-04 | $2.14M 10-Q · filed 2021-11-04 | |
| 2020-06-30 | -$394.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $1.07M 10-Q · filed 2021-08-05 | ||
| 2020-03-31 | $1.47M 10-Q · filed 2021-05-25 | |||
| 2019-12-31 | -$236.00K 10-K · filed 2022-03-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |